Results about: business
An innovative programme from IRB Barcelona’s Innovation Department enables researchers to explore how to implement their entrepreneurial ideas
Storytelling is one of a scientist's greatest assets, says Novartis Oncology Brand Manager Albert Farré
How do you make a successful move from academia to industry? In March, Albert Farré, Brand Manager at Novartis Oncology, told IRB Barcelona scientists who attended the “Building Bridges in your network” workshop how he did it. And he has some good advice for budding entrepreneurs.
IRB Barcelona fosters entrepreneurship among its young scientists. Two postdoctoral fellows tell in vivo about their experience of learning how to deal with markets, patents and venture capitalists.
The goal is to speed up the transfer of technologies developed in the six BIST research institutes to the marketplace.
IRB Barcelona takes part in the co-session "Science is Business", a meeting space to explore new co-innovation pathways
Today the Barcelona Science Park (PCB) hosts the co-session 'Science is Business', organised by Co-society–Infonomia´s innovation platform– in collaboration with the Institute for Biomedical Research (IRB Barcelona) and PCB. The aim of the conference is to present examples of 'quick' conversion of science into business and open a space for dialogue and exchange of experiences among researchers, business people and entrepreneurs to find new ways to connect science and business, and overcome the shortcomings of typical knowledge transfer mechanisms.
PCB hosts the co-session 'Science is Business, a meeting space to explore new co-innovation pathways
“Cafè amb la Recerca” (Research over a coffee), organised by the “Fundació Catalana per a la Recerca i la Innovació”, seeks to offer a meeting point in which research centres, companies, and investors can explore collaboration initiatives.
In the first session of this series, Joan J. Guinovart, director of the IRB Barcelona and Josep Samitier, director of the IBEC presented their research lines to eight managerial representatives from the business and investment sectors.
IRB Barcelona launches a Business Advisory Board (BAB) to speed up technology transfer.
The BAB comprises distinguished representatives from pharmaceutical companies, venture capital enterprises, and agents specialized in promoting agreements between the public and private sectors.
Appraisal of innovation issues by the BAB is expected to boost the set up of new spin-offs, patent licenses, and the establishment of stable collaboration agreements with pharmaceutical companies around the world.